logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
许

许宝红 (Baohong Xu)

hunan agricultural university
H指数:15
被引数:812

个人简介

任职于湖南农业大学动物科技学院水产系，副教授。2012年获湖南农业大学水生生物学博士学位，2016-2017年赴美国罗格斯大学访学。研究方向为鱼类抗性基因筛选与功能验证，专注于鱼类疾病中补体因子的相关研究。主讲本科生课程《水域环境化学》《观赏水草栽培学》及研究生课程《生物信息学》《水产动物遗传学》。主持国家级、省级和校级教改科研项目10余项，发表教改科研论文30余篇，副主编十三五规划教材1部，参编2部，获授权国家发明专利1项。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

1058c MUFEMILAST (ORAL PDE4 INHIBITOR) FOR ULCERATIVE COLITIS: OPEN-LABEL EXTENSION RESULTS AT 24 WEEKS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL GROUP INDUCTION PHASE II CLINICAL TRIAL

1058c MUFEMILAST（口服PDE4抑制剂）治疗溃疡性结肠炎：一项多中心、随机、双盲、安慰剂对照平行组诱导期II期临床试验24周开放标签扩展研究结果

Gastrointestinal Endoscopy
IF7.5
2026-05-010
PRE
Charles R. Jones; Laurent Peyrin Biroulet; Shutian Zhang; Changqing Zheng; Xiuli Zuo; Xiaoyun DIng; Liangping Li; Youxiang Chen; Xu Ren; Xiaowei Liu; Chengxia Liu; Bangmao Wang; Hong Guo; Baohong Xu; Ruimiao Yu; Feng Tian; Xiaihua Huo; Hui Yang; Zhaohui Yu; Xiangpeng Hu
1058c MUFEMILAST (ORAL PDE4 INHIBITOR) FOR ULCERATIVE COLITIS: OPEN-LABEL EXTENSION RESULTS AT 24 WEEKS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL GROUP INDUCTION PHASE II CLINICAL TRIAL

1058c：MUFEMILAST（口服PDE4抑制剂）治疗溃疡性结肠炎：一项多中心、随机、双盲、安慰剂对照平行组II期诱导临床试验24周开放标签扩展研究结果

Gastroenterology
IF25.1
2026-05-010
PRE
Charles R. Jones; Laurent Peyrin Biroulet; Shutian Zhang; Changqing Zheng; Xiuli Zuo; Xiaoyun DIng; Liangping Li; Youxiang Chen; Xu Ren; Xiaowei Liu; Chengxia Liu; Bangmao Wang; Hong Guo; Baohong Xu; Ruimiao Yu; Feng Tian; Xiaihua Huo; Hui Yang; Zhaohui Yu; Xiangpeng Hu
Dietary macroalgae enhances amino acid metabolism via intestinal Shewanella in grass carp (Ctenopharyngodon idella)

dietary macroalgae 通过肠道 Shewanella 增强 草鱼 (Ctenopharyngodon idella) 的氨基酸代谢

Advanced Biotechnology
IF0
2025-12-140
OA
An, Xingxing; Niu, Shuhui; Al, Mamun Abdullah; Su, Erxin; Chen, Lin; He, Houxiong; Wang, Yaohua; Zhang, Song; Yang, Yong; Wang, Shen; Wen, Zheyu; Xu, Baohong; Ming, Yuzhen; Zhu, Wengen; Zhao, Zhenrui; Wu, Kun; Yang, Yufeng; Xie, Wei; He, Zhili; Yan, Qingyun
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Etrasimod作为东亚中度至重度活动性溃疡性结肠炎患者的诱导和维持治疗方案（ENLIGHT UC）：一项随机、双盲、安慰剂对照、多中心、III期研究

The Lancet Gastroenterology & Hepatology
IF38.6
2025-09-300
PRE
Kaichun Wu; Changqing Zheng; Qian Cao; Yijuan Ding; Xiang Gao; Jie Zhong; Cheng-Tang Chiu; Hu Zhang; Xin Wang; Bangmao Wang; Jie Liang; Xiaowei Liu; Yongjian Zhou; Baohong Xu; Tae-Oh Kim; Xizhong Shen; Dongfeng Chen; Weichang Chen; Yulan Liu; Jun Shen; Fei Liu; Xiaoyun Ding; Qiang Zhan; Jen-Wei Chou; Sandra Zeng; Yun Lin; Lisa Ying; Xia Chen
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

在中国功能性便秘患者中plercanatide的疗效与安全性：一项III期多中心、随机、双盲、安慰剂对照试验

Drugs
IF14.4
2025-06-260
PRE
Tao Bai; Zhiyue Xu; Yanbo Zhen; Aijun Liao; Bangmao Wang; Rong Zhao; Yin Zhu; Ning Dai; Side Liu; Hong Zhao; Xi Chen; Kunming Huang; Min Xu; Weizhen Zhou; Baohong Xu; Bin Ye; Duowu Zou; Heng Zhang; Ruihua Shi; Juan Zhang; Yaowei Ai; Xiangming Fang; Lin Lin; Xiaolan Zhang; Ling Zhang; Junping Wang; Yueping Jiang; Jun Cui; Mingxin Zhang; Xiangwu Ding; Zhongyin Zhou; Peng Yan; Xiaoqing Li; Bo Jiang; Youli Liu; Yingcai Ma; Shaoqi Yang; Xiaoyan Wang; Yongdong Wu; Jianjun Wu; Huixin Chen; Xiaohua Hou
A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (X842) and Lansoprazole for the Treatment of Patients With Erosive Esophagitis

一项关于钾竞争性酸阻滞剂（X842）与兰索拉唑治疗糜烂性食管炎患者的随机对照试验

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
IF3
2025-01-210
OA
Zhu, Siying; Han, Muzhou; Zong, Ye; Meng, Fandong; Liu, Qi; Tuo, Biguang; Zhang, Zhenyu; Wang, Qizhi; Liu, Xiaowei; He, Song; Zhen, Yanbo; Shao, Dong; Wang, Shenglan; Xu, Baohong; Li, Xing; Tang, Haitao; Miu, Yangde; Liu, Chengxia; Hu, Jiuye; Hu, Pingsheng; Xiu, Jin; Lu, Ming; Wu, Yongdong; Zhang, Shutian
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
2024-01-225
PRE
Zhuang, Qianjun; Liao, Aijun; He, Qingling; Liu, Chengxia; Zheng, Changqing; Li, Xing; Liu, Youli; Wang, Bangmao; Liu, Side; Zhang, Yan; Lin, Rong; Chen, Huixin; Deng, Min; Tang, Yanping; He, Chiyi; Dai, Weijie; Tang, Haitao; Gong, Lei; Li, Liangping; Xu, Baohong; Yang, Changqing; Zhou, Bingxi; Su, Dongxing; Guo, Qinghong; Li, Bin; Zhou, Yongjian; Wang, Xiaoyang; Fei, Sujuan; Wu, Huili; Wei, Sichen; Peng, Zhihong; Wang, Jianning; Li, Yanqing; Wang, Hong; Deng, Tianwei; Ding, Shigang; Li, Fangfang; Chen, Minhu; Xiao, Yinglian
Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients

鼻咽微生物组中的超级优势病原共生细菌会导致新型冠状病毒肺炎患者的继发性细菌感染

MICROBIOLOGY SPECTRUM
IF3.8
2022-06-2917
OAAI
Qin, Tian; Wang, Yajie; Deng, Jianping; Xu, BaoHong; Zhu, Xiong; Wang, Jitao; Zhou, Haijian; Zhao, Na; Jin, Fangfang; Ren, Hongyu; Wang, Huizhu; Li, Qun; Xu, Xinmin; Guo, Yumei; Li, Ruihong; Xiong, Yanwen; Wang, XiaoXia; Guo, Jiane; Zheng, Han; Hou, Xuexin; Wan, Kanglin; Zhang, Jianzhong; Lu, Jinxing; Kan, Biao; Xu, Jianguo

研究方向

鱼类抗逆性状分子育种
刘
刘巧林
H 指数:12论文数:74被引数:849
吕
吕钊
H 指数:18论文数:58被引数:847
T
Tiaoyi Xiao
H 指数:17论文数:172被引数:990
H 指数:0论文数:21被引数:0
R
Ren Xu
H 指数:30论文数:206被引数:4,858
H
Hui Yang
H 指数:30论文数:387被引数:3,762
Y
Yan Shi
H 指数:45论文数:314被引数:8,474
Y
Yuhong Huang
H 指数:7论文数:29被引数:205
X
Xiaoyan Wang
H 指数:54论文数:606被引数:1.1万
L
Lan Sun
H 指数:20论文数:60被引数:2,102